Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of vonoprazan on intestinal flora in patients with acid-related disease
ChiCTR2100047119Phase 4Recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vonoprazan in gastritis and gastroesophageal reflux disease (GERD), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Change in intestinal flora diversity and composition and Relief of reflux, heartburn, and related symptoms. Started Jun 2021; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
gastritisgastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ChiCTR2100047119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047119.